United States

Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K/A

 

Amendment No. 1

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

September 2, 2008

 

Prospect Medical Holdings, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

1-32203

 

33-0564370

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

10780 Santa Monica Blvd., Suite 400

 

 

Los Angeles, California

 

90025

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (310) 943-4500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 4.01                                                  Changes in Registrant’s Certifying Accountant.

 

On September 2, 2008, we dismissed Ernst & Young LLP (the “Former Auditors”) as our independent registered public accounting firm and retained BDO Seidman, LLP (the “New Auditors”) to serve as our independent registered public accounting firm for the fiscal year ending September 30, 2008. Our Audit Committee approved the change in auditors on August 29, 2008.

 

In connection with the audits of our financial statements for the fiscal years ended September 30, 2006 and 2007, and in the subsequent interim period through September 2, 2008, the date of the dismissal of the Former Auditors, there were no disagreements with the Former Auditors on any matter of accounting principles or practices, financial statement disclosure or auditing scope and procedure which, if not resolved to the satisfaction of the Former Auditors, would have caused them to make reference to the subject matter of the disagreement in connection with their report.  Neither of the Former Auditor’s reports on our consolidated financial statements for the fiscal years ended September 30, 2006 and September 30, 2007 contained an adverse opinion or disclaimer of opinion or was qualified or modified as to uncertainty, audit scope or accounting principles.

 

In connection with their audit of our consolidated financial statements for the fiscal year ended September 30, 2007, the Former Auditors noted certain material weaknesses in our internal control over financial reporting, which we have previously disclosed in our annual report on Form 10-K for the year ended September 30, 2007 and in our quarterly reports on Form 10-Q for the periods ended December 31, 2007, March 31, 2008 and June 30, 2008 (the “Reports”). The material weaknesses were identified following our acquisition of Alta Hospitals System, LLC (“Alta”) on August 8, 2007 and related to certain material errors in the previously issued financial statements of Alta for its fiscal year ended December 31, 2006 and material adjustments that were required to be made to Alta’s interim financial statements as of and for the six months ended June 30, 2007. As more fully described in the Reports, the material weaknesses noted were in the areas of recording reimbursements due from third-party payors related to open cost report years; accounting for receivables from government disproportionate share programs; valuation of general hospital accounts receivable balances; a lack, at that time, of the necessary finance personnel at Alta with specific expertise to evaluate all appropriate data and accounting considerations related to these areas and knowledgeable personnel capable of overseeing and evaluating work performed by outside consultants working on Alta’s behalf; and, as a result of acquisitions completed in 2007, significant changes in our corporate and financial reporting structure that resulted in our having a multi-location, multi-tier reporting and consolidation process with decentralized accounting functions at each of our reporting units, which significantly taxed our finance and accounting resources existing at the time and as a result, we did not make timely filings of our Form 10-K for the year ended September 30, 2007 and Forms 10-Q for the quarters ended December 31, 2007 and March 31, 2008. We have authorized the Former Auditors to respond fully to inquiries of the New Auditors concerning the subject matter of these material weaknesses. We have also requested the Former Auditors to furnish us a letter addressed to the Commission stating whether they agree with the above statements. A copy of their letter dated September 16, 2008, is filed as Exhibit 99.1 to this report.

 

Prior to September 2, 2008, including for the fiscal years ended September 30, 2006 and 2007 and the subsequent interim period through September 2, 2008, neither we nor anyone acting on our behalf has consulted with the New Auditors concerning the application of accounting principles to any specific completed or contemplated transaction, the type of audit opinion that might be rendered on our consolidated financial statements, or any other matter.

 

Item 9.01.              Financial Statements and Exhibits

 

(d)           Exhibits

 

The following exhibits are filed with the Form 8-K:

 

Exhibit No.

 

Description

99.1

 

Letter of Ernst & Young LLP dated September 16, 2008

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PROSPECT MEDICAL HOLDINGS, INC.

 

 

 

 

 

By:

/s/ MIKE HEATHER

 

 

Mike Heather

 

 

Chief Financial Officer

 

 

Dated: September 16, 2008

 

 

3


Prospect Medical (AMEX:PZZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Prospect Medical.
Prospect Medical (AMEX:PZZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Prospect Medical.